View current insulin pumps from a variety of manufacturers. Compare features and technical specifications and find training resources, affordability information, prescription details and more.
View features and specifications of popular infusion sets to determine the best option for your patients and clients.
View and compare features and technical specifications for current traditional pens, connected pens, inhaled options and patches for insulins, glucagon and other medicines to help manage diabetes.
Proper basal insulin initiation and titration can help reduce therapeutic inertia and engage patients in their diabetes management. Find videos, podcasts and other resources to fine tune your knowledge.
Find a sample of the latest online apps and digital platforms designed to prevent, manage and/or treat diabetes. We highlight apps and DTx for people with diabetes as well as the professionals treating them.
An overview of Glycemic Management Platforms that answers key questions including: What are they? What to consider? How can my inpatient facility benefit and more.
Are prior authorizations delaying patient care? Is your team overwhelmed by manual workflows? These platforms might help.
Find diabetes certificate programs, online learning opportunities, webinars, device training, practical tools and more. All resources are developed for diabetes healthcare professionals by diabetes healthcare professionals.
Find a variety of podcasts and videos focused on the latest topics in diabetes technology specifically created for diabetes healthcare professionals.
Learn about the diabetes technology competencies that are essential for all levels of the care team and support staff in various care settings to deliver comprehensive diabetes management and support to person living with diabetes.
Danatech device trainings introduce healthcare professionals to the latest diabetes technology including the newest CGMs, automated insulin delivery devices, smart pens and more. Trainings include overviews, training specifics, FAQs and more.
Coding, billing and reimbursement information for wearable CGMs, implantable CGMs, AID training and more.
Help tackle cardiovascular issues by equipping yourself with the knowledge to reduce cardiometabolic risk and combat the development of cardiometabolic diseases with specialized education and resources from danatech.
Find key points on T1D screening, including how to discuss screening with clients and families, psychosocial and health equity aspects of screening and heightening awareness about T1D as a pre-clinical autoimmune disease.
Whether you’re a healthcare professional seeking to enhance your expertise or someone passionate about making a significant impact in the lives of those affected by diabetes, this guide will help you navigate the path to becoming a CDCES.
Discover how spinal cord stimulation (SCS) using electrodes implanted near the spinal cord deliver electrical pulses that disrupt pain signals traveling to the brain and improve quality of life for patients with diabetic peripheral neuropathy (DPN).
Recent diabetes technology innovations, product launches and enhancements as well as clinical perspectives regarding diabetes care.
Written by: ADCES staff and subject matter expert faculty
May 27, 2025
Randomized controlled trials have demonstrated:
Results from the three-year follow-up to the COMISAIR Study, which were published in Diabetes Care in January 2020, demonstrated that CGM is superior to self-monitoring of fingerstick glucose in reduction of HbA1c, hypoglycemia and other end points in people with type 1 diabetes regardless of their insulin delivery method. They went on to say that CGM plus multiple daily insulin injections can be considered an equivalent but lower-cost alternative to sensor-augmented insulin pump therapy and superior to treatment with self-monitoring of fingerstick glucose plus multiple daily insulin injections or self-monitoring of fingerstick glucose plus continuous subcutaneous insulin infusion therapy.
Published in Diabetes Technology & Therapeutics in 2019, Mulinacci et al7 investigated the efficacy and safety of CGM initiation within one year of type 1 diabetes diagnosis among all age groups. They concluded that “Irrespective of insulin delivery system, early initiation of CGM within one year from T1D diagnosis was associated with better glucose control and fewer diabetes-related emergency visits.”
Many studies have been performed with multiple populations and different device types: people with type 1 and type 2 diabetes, adults and children, personal and professional CGM. Dr. Anne Peters, Endocrinologist at the Keck School of Medicine at University of Southern California, provided a detailed review of CGM studies and outcomes in the Role of Continuous Glucose Monitoring in Diabetes Treatment supplement published by the American Diabetes Association (Chart used by permission, American Diabetes Association, 2018).
References:
Integrating Diabetes Technology into Primary Care Part 1: Overview and Clinical Scenarios
Integrating Diabetes Technology into Primary Care Part 2: Interactive Case Studies
Putting Continuous Glucose Monitoring (CGM) into Practice Certificate Program, FREE for members
DISCLAIMERS:
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.